U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281599) titled 'Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer' on Dec. 03.
Brief Summary: The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing.
At a later clinic visit, the same participants will have a standard cervical sample collected for routine hrHPV testing...